Aspirin and prostate cancer prevention.
作者信息
Vidal Adriana C, Freedland Stephen J
机构信息
Department of Surgery, Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA 90048, USA.
出版信息
Aging (Albany NY). 2015 May;7(5):292-3. doi: 10.18632/aging.100747.
Abstract
摘要
相似文献
1
Aspirin and prostate cancer prevention.
Aging (Albany NY). 2015 May;7(5):292-3. doi: 10.18632/aging.100747.
2
Daily aspirin may thwart prostate cancer.
Health News. 2002 May;8(5):9.
3
Aspirin and prostate cancer prevention.
Recent Results Cancer Res. 2014;202:93-100. doi: 10.1007/978-3-642-45195-9_11.
4
Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts.
Cancer Prev Res (Phila). 2017 Jul;10(7):410-420. doi: 10.1158/1940-6207.CAPR-17-0033. Epub 2017 May 15.
5
6
Aspirin, salicylates, and cancer.
Lancet. 2009 Apr 11;373(9671):1301-9. doi: 10.1016/S0140-6736(09)60243-9. Epub 2009 Mar 26.
7
Nutritional prevention of cancer: new directions for an increasingly complex challenge.
J Natl Cancer Inst. 2009 Mar 18;101(6):363-5. doi: 10.1093/jnci/djp029. Epub 2009 Mar 10.
8
Association of nonsteroidal anti-inflammatory drugs, prostate specific antigen and prostate volume.
J Urol. 2009 May;181(5):2064-70. doi: 10.1016/j.juro.2009.01.031. Epub 2009 Mar 14.
9
Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study.
Br J Cancer. 2012 Jun 26;107(1):207-14. doi: 10.1038/bjc.2012.227. Epub 2012 Jun 21.
10
Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population.
Eur J Cancer Prev. 2006 Apr;15(2):158-64. doi: 10.1097/01.cej.0000197451.02604.25.
引用本文的文献
1
The most effective but largely ignored target for prostate cancer early detection and intervention.
J Cancer. 2022 Oct 17;13(13):3463-3475. doi: 10.7150/jca.72973. eCollection 2022.
2
Sex-associated preventive effects of low-dose aspirin on obesity and non-alcoholic fatty liver disease in mouse offspring with over-nutrition in utero.
Lab Invest. 2019 Feb;99(2):244-259. doi: 10.1038/s41374-018-0144-2. Epub 2018 Nov 9.
3
Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study.
Contemp Clin Trials Commun. 2017 Jun;6:105-114. doi: 10.1016/j.conctc.2017.03.005. Epub 2017 Mar 27.
4
AMPK-mediated up-regulation of mTORC2 and MCL-1 compromises the anti-cancer effects of aspirin.
Oncotarget. 2016 Mar 29;7(13):16349-61. doi: 10.18632/oncotarget.7648.
本文引用的文献
1
Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study.
Clin Cancer Res. 2015 Feb 15;21(4):756-62. doi: 10.1158/1078-0432.CCR-14-2235. Epub 2014 Dec 17.
2
Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.
Br J Cancer. 2014 Sep 23;111(7):1421-31. doi: 10.1038/bjc.2014.381. Epub 2014 Jul 10.
3
Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis.
BMC Med. 2014 Mar 28;12:55. doi: 10.1186/1741-7015-12-55.
4
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.
Lancet. 2012 Apr 28;379(9826):1602-12. doi: 10.1016/S0140-6736(11)61720-0. Epub 2012 Mar 21.
5
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
Lancet. 2011 Dec 17;378(9809):2081-7. doi: 10.1016/S0140-6736(11)61049-0. Epub 2011 Oct 27.
6
Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis.
Int J Cancer. 2010 Oct 1;127(7):1680-91. doi: 10.1002/ijc.25186.
Zotero 插件